BioSpace News Archive

As the community of kidney care professionals convenes for the annual American Society of Nephrology (ASN) Kidney Week in San Diego,

Women veterans felt empowered as they connected on their own terms during a weekend in the Florida Keys organized by Wounded Warrior Project® (WWP).

MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today that Dr. Eggert Stockfleth, Director of the University Department of Dermatology at St. Josef-Hospital in Bochum, Germany has agreed to join MedX’s Medical Advisory Board.

Scientists at Morinaga Milk Industry Co., Ltd. (TOKYO:2264) have long theorized that Human-Residential Bifidobacteria (HRB) are superior to non-Human-Residential Bifidobacteria (non-HRB) in promoting good health outcomes.

AMO Pharma Limited (“AMO Pharma”), a privately held biopharmaceutical company focusing on rare, debilitating diseases with limited or no treatment options, today announced the presentation of results from a concordant trend analysis of a Phase 2 clinical study of AMO-02 for the treatment of congenital and childhood onset myotonic dystrophy type 1

The medical community is at odds on how best to treat Lyme disease in patients who do not respond well to short-term antibiotics.

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the initiation of its Phase I dose-escalation clinical trial with the novel mRNA-based rabies vaccine, CV7202.

FutureCeuticals, Inc. is proud to introduce S7™, the newest addition to its sports nutrition line of branded ingredients.

TransPerfect Medical Device Solutions, the world’s largest provider of language services and process automation technology to the medical device industry, today announced the introduction of its new EnCompass Rapid Prototyping Program.

Scientia Vascular, LLC, a commercial-stage medical device company with patented, proprietary, and FDA-approved vascular access technology, recently appointed Rick Randall as executive director to its board.